AAAAAA
Results: 1-25/39
Authors:
Feldmann, M
Brennan, FM
Foxwell, BMJ
Maini, RN
Citation: M. Feldmann et al., The role of TNF alpha and IL-1 in rheumatoid arthritis, CURR DIR AU, 3, 2001, pp. 188-199
Authors:
Bondeson, J
Maini, RN
Citation: J. Bondeson et Rn. Maini, Tumour necrosis factor as a therapeutic target in rheumatoid arthritis andother chronic inflammatory diseases: The clinical experience with infliximab (Remicade (TM)), INT J CL PR, 55(3), 2001, pp. 211-216
Authors:
Taylor, PC
Williams, RO
Maini, RN
Citation: Pc. Taylor et al., Immunotherapy for rheumatoid arthritis, CURR OP IM, 13(5), 2001, pp. 611-616
Authors:
Feldmann, M
Maini, RN
Citation: M. Feldmann et Rn. Maini, Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?, ANN R IMMUN, 19, 2001, pp. 163-196
Authors:
Feldmann, M
Maini, RN
Bondeson, J
Taylor, P
Foxwell, BMJ
Brennan, FM
Citation: M. Feldmann et al., Cytokine blockade in rheumatoid arthritis, ADV EXP MED, 490, 2001, pp. 119-127
Authors:
Ballara, S
Taylor, PC
Reusch, P
Marme, D
Feldmann, M
Maini, RN
Paleolog, EM
Citation: S. Ballara et al., Raised serum vascular endothelial growth factor levels are associated withdestructive change in inflammatory arthritis, ARTH RHEUM, 44(9), 2001, pp. 2055-2064
Authors:
Charles, P
Maini, RN
Citation: P. Charles et Rn. Maini, Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on the article by Charles et al - Reply, ARTH RHEUM, 44(8), 2001, pp. 1968-1968
Authors:
Malfait, AM
Williams, RO
Malik, AS
Maini, RN
Feldmann, M
Citation: Am. Malfait et al., Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as amodel for testing disease-modifying and remission-inducing therapies, ARTH RHEUM, 44(5), 2001, pp. 1215-1224
Authors:
Taylor, PC
Paleolog, E
Maini, RN
Citation: Pc. Taylor et al., Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply, ARTH RHEUM, 44(1), 2001, pp. 245-246
Authors:
Zvaifler, NJ
Marinova-Mutafchieva, L
Adams, G
Edwards, CJ
Moss, J
Burger, JA
Maini, RN
Citation: Nj. Zvaifler et al., Mesenchymal precursor cells in the blood of normal individuals, ARTHRITIS R, 2(6), 2000, pp. 477-488
Authors:
Taylor, PC
Williams, RO
Maini, RN
Citation: Pc. Taylor et al., Anti-TNF alpha therapy in rheumatoid arthritis - Current and future directions, CURR DIR AU, 2, 2000, pp. 83-102
Authors:
Bondeson, J
Feldmann, M
Maini, RN
Citation: J. Bondeson et al., TNF as a therapeutic target, IMMUNOLOGIS, 8(6), 2000, pp. 136-140
Authors:
Maini, RN
Taylor, PC
Citation: Rn. Maini et Pc. Taylor, Anti-cytokine therapy for rheumatoid arthritis, ANN R MED, 51, 2000, pp. 207-229
Authors:
Lipsky, PE
van der Heijde, DMFM
St Clair, EW
Furst, DE
Breedveld, FC
Kalden, JR
Smolen, JS
Weisman, M
Emery, P
Feldmann, M
Harriman, GR
Maini, RN
Citation: Pe. Lipsky et al., Infliximab and methotrexate in the treatment of rheumatoid arthritis, N ENG J MED, 343(22), 2000, pp. 1594-1602
Authors:
Williams, RO
Marinova-Mutafchieva, L
Feldmann, M
Maini, RN
Citation: Ro. Williams et al., Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy, J IMMUNOL, 165(12), 2000, pp. 7240-7245
Authors:
Marinova-Mutafchieva, L
Taylor, P
Funa, K
Maini, RN
Zvaifler, NJ
Citation: L. Marinova-mutafchieva et al., Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint, ARTH RHEUM, 43(9), 2000, pp. 2046-2055
Authors:
Charles, PJ
Smeenk, RJT
De Jong, J
Feldmann, M
Maini, RN
Citation: Pj. Charles et al., Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha - Findings in open-label and randomized placebo-controlled trials, ARTH RHEUM, 43(11), 2000, pp. 2383-2390
Authors:
Ulfgren, AK
Andersson, U
Engstrom, M
Klareskog, L
Maini, RN
Taylor, PC
Citation: Ak. Ulfgren et al., Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis, ARTH RHEUM, 43(11), 2000, pp. 2391-2396
Authors:
Taylor, PC
Peters, AM
Paleolog, E
Chapman, PT
Elliot, MJ
McCloskey, R
Feldmann, M
Maini, RN
Citation: Pc. Taylor et al., Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis, ARTH RHEUM, 43(1), 2000, pp. 38-47
Authors:
Smolen, JS
Breedveld, FC
Burmester, GR
Combe, B
Emery, P
Kalden, JR
Klareskog, L
Maini, RN
Numo, R
van de Putte, LBA
van Riel, PLCM
Rodriguez-Valverde, V
Citation: Js. Smolen et al., Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis, ANN RHEUM D, 59(7), 2000, pp. 504-505
Authors:
Furst, DE
Breedveld, FC
Burmester, GR
Crofford, JJ
Emery, P
Feldmann, M
Kalden, JR
Kavanaugh, AF
Keystone, EC
Klareskog, LG
Lipsky, PE
Maini, RN
Russell, AS
Scott, DL
Smolen, JS
Van de Putte, LBA
Visher, TL
Weisman, MH
Citation: De. Furst et al., Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000), ANN RHEUM D, 59, 2000, pp. 1-2
Authors:
Williams, RO
Feldmann, M
Maini, RN
Citation: Ro. Williams et al., Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha, ANN RHEUM D, 59, 2000, pp. 75-80
Authors:
Feldmann, M
Miotla, J
Paleolog, E
Williams, R
Malfait, AM
Taylor, P
Brennan, FM
Maini, RN
Citation: M. Feldmann et al., Future prospects for anti-cytokine treatment, ANN RHEUM D, 59, 2000, pp. 119-122
Authors:
Maini, RN
Citation: Rn. Maini, The debut of anti-TNF therapy of rheumatoid arthritis in the clinic, PROG INFLAM, 2000, pp. 145-156
Authors:
Feldmann, M
Maini, RN
Citation: M. Feldmann et Rn. Maini, The role of cytokines in the pathogenesis of rheumatoid arthritis, RHEUMATOLOG, 38, 1999, pp. 3-7